{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:41:48Z","timestamp":1790023308207,"version":"4.0.1"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013779","name":"Retina Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001694","name":"International Retinal Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010657","name":"Carl Marshall and Mildred Almen Reeves Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00095","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T07:41:17Z","timestamp":1549525277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future"],"prefix":"10.3389","volume":"10","author":[{"given":"Bomina","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Corson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbrc.2014.03.020","article-title":"Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells.","volume":"446","author":"Askari","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1021\/acs.jmedchem.5b00449","article-title":"Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization.","volume":"58","author":"Basavarajappa","year":"2015","journal-title":"J. Med. Chem."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010469.pub2","article-title":"Corticosteroid implants for chronic non-infectious uveitis.","volume":"2","author":"Brady","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B4","first-page":"91","article-title":"Dietary deficiency of N-3 fatty acids alters rhodopsin content and function in the rat retina.","volume":"35","author":"Bush","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 fatty acids and inflammatory processes.","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"key":"B6","article-title":"The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.","volume":"5","author":"Campochiaro","year":"1999","journal-title":"Mol. Vis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/srep39211","article-title":"Epoxygenated fatty acids inhibit retinal vascular inflammation.","volume":"6","author":"Capozzi","year":"2016","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1167\/iovs.14-14216","article-title":"The role of cytochrome P450 epoxygenases in retinal angiogenesis.","volume":"55","author":"Capozzi","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0003-9861(83)90628-8","article-title":"The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase.","volume":"223","author":"Chacos","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3791\/313","article-title":"Intravitreous injection for establishing ocular diseases model.","volume":"2007","author":"Chiu","year":"2007","journal-title":"J. Vis. Exp."},{"key":"B11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.","volume":"13","author":"Connor","year":"2007","journal-title":"Nat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.preteyeres.2003.08.001","article-title":"Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition.","volume":"22","author":"Das","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature.","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"key":"B14","first-page":"961","article-title":"Drug delivery for posterior segment eye disease.","volume":"41","author":"Geroski","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1161\/ATVBAHA.116.307558","article-title":"Cytochrome P450 oxidase 2C inhibition adds to \u03c9-3 long-chain polyunsaturated fatty acids protection against retinal and choroidal neovascularization.","volume":"36","author":"Gong","year":"","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ebiom.2016.09.025","article-title":"Fenofibrate inhibits cytochrome P450 epoxygenase 2C activity to suppress pathological ocular angiogenesis.","volume":"13","author":"Gong","year":"","journal-title":"eBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3945\/ajcn.117.153825","article-title":"\u03c9-3 and \u03c9-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.","volume":"106","author":"Gong","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132643","article-title":"Optimization of an image-guided laser-induced choroidal neovascularization model in mice.","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS One"},{"key":"B19","article-title":"Histopathology of age-related macular degeneration.","volume":"5","author":"Green","year":"1999","journal-title":"Mol. Vis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/vaa.12030","article-title":"Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis.","volume":"40","author":"Guedes","year":"2013","journal-title":"Vet. Anaesth. Analg."},{"key":"B21","article-title":"Age-related macular degeneration (AMD)","author":"Hageman","year":"2008","journal-title":"The Organization of the Retina and Visual System"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.2337\/diabetes.51.10.3107","article-title":"Pericytes and the pathogenesis of diabetic retinopathy.","volume":"51","author":"Hammes","year":"2002","journal-title":"Diabetes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gene.2013.05.008","article-title":"Soluble epoxide hydrolase: gene structure, expression and deletion.","volume":"526","author":"Harris","year":"2013","journal-title":"Gene"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E7545","DOI":"10.1073\/pnas.1620898114","article-title":"Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.","volume":"114","author":"Hasegawa","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4161\/cam.1.3.4978","article-title":"VEGF and notch signaling: the yin and yang of angiogenic sprouting.","volume":"1","author":"Hellstr\u00f6m","year":"2007","journal-title":"Cell Adh. Migr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature25013","article-title":"Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy.","volume":"552","author":"Hu","year":"2017","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1084\/jem.20131494","article-title":"Muller glia cells regulate notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid.","volume":"211","author":"Hu","year":"2014","journal-title":"J. Exp. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1021\/jm070270t","article-title":"Orally bioavailable potent soluble epoxide hydrolase inhibitors.","volume":"50","author":"Hwang","year":"2007","journal-title":"J. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"18901","DOI":"10.1073\/pnas.0809765105","article-title":"Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways.","volume":"105","author":"Inceoglu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080922","article-title":"Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures.","volume":"8","author":"Inceoglu","year":"2013","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/bjo.2004.055541","article-title":"Prevention of diabetic keratopathy.","volume":"89","author":"Kaji","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/EB.S94447","article-title":"Revisiting the mouse model of oxygen-induced retinopathy.","volume":"8","author":"Kim","year":"2016","journal-title":"Eye Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4155\/TDE.10.40","article-title":"Recent advances in ophthalmic drug delivery.","volume":"1","author":"Kompella","year":"2010","journal-title":"Ther. Deliv."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1124\/dmd.116.069369","article-title":"Drug transport by the blood\u2013aqueous humor barrier of the eye.","volume":"44","author":"Lee","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1021\/jm500694p","article-title":"Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.","volume":"57","author":"Lee","year":"2014","journal-title":"J. Med. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.2741\/3438","article-title":"Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.","volume":"14","author":"Li","year":"2009","journal-title":"Front. Biosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/bjo.2006.113902","article-title":"Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.","volume":"91","author":"Lux","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.18240\/ijo.2017.02.19","article-title":"The omega-3 and retinopathy of prematurity relationship.","volume":"10","author":"Malamas","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.13188\/2334-2838.1000024","article-title":"Effect of a soluble epoxide hydrolase inhibitor, UC1728, on LPS-induced uveitis in the rabbit.","volume":"4","author":"McLellan","year":"2016","journal-title":"J. Ocul. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1167\/iovs.07-1087","article-title":"Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells.","volume":"49","author":"Michaelis","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.prostaglandins.2018.05.004","article-title":"An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats.","volume":"136","author":"Minaz","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9570.1000187","article-title":"Effects of docosahexaenoic acid in preventing experimental choroidal neovascularization in rodents.","volume":"2","author":"Moghaddam-Taaheri","year":"2011","journal-title":"J. Clin. Exp. Ophthalmol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1194\/jlr.M006007","article-title":"Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids.","volume":"51","author":"Morisseau","year":"2010","journal-title":"J. Lipid Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/01.RES.83.9.932","article-title":"Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.","volume":"83","author":"Oltman","year":"1998","journal-title":"Circ. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1172\/JCI58128","article-title":"Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.","volume":"122","author":"Panigrahy","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13528","DOI":"10.1073\/pnas.1311565110","article-title":"Epoxyeicosanoids promote organ and tissue regeneration.","volume":"110","author":"Panigrahy","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.prostaglandins.2013.02.001","article-title":"In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor.","author":"Podolin","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B49","doi-asserted-by":"publisher","first-page":"27138","DOI":"10.1074\/jbc.M501730200","article-title":"Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids.","volume":"280","author":"Pozzi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/748361","article-title":"Retina and omega-3.","volume":"2011","author":"Querques","year":"2011","journal-title":"J. Clin. Nutr. Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1073\/pnas.1616893114","article-title":"Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids.","volume":"114","author":"Rand","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/glia.22477","article-title":"New functions of muller cells.","volume":"61","author":"Reichenbach","year":"2013","journal-title":"Glia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","article-title":"The economic burden of major adult visual disorders in the United States.","volume":"124","author":"Rein","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1021\/jm100691c","article-title":"1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.","volume":"53","author":"Rose","year":"2010","journal-title":"J. Med. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/eye.2009.306","article-title":"Oxygen-induced retinopathy: a model for vascular pathology in the retina.","volume":"24","author":"Scott","year":"2009","journal-title":"Eye"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069552","article-title":"Choroid sprouting assay: an ex vivo model of microvascular angiogenesis.","volume":"8","author":"Shao","year":"2013","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/ATVBAHA.113.302927","article-title":"Cytochrome P450 2C8 \u03c93-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization\u2014brief report.","volume":"34","author":"Shao","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1016\/j.bmcl.2009.08.006","article-title":"A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.","volume":"19","author":"Shen","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/jm201468j","article-title":"Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.","volume":"55","author":"Shen","year":"2012","journal-title":"J. Med. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.2353\/ajpath.2010.100526","article-title":"Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.","volume":"177","author":"Stahl","year":"","journal-title":"Am. J. Pathol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/circresaha.110.221317","article-title":"Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy.","volume":"107","author":"Stahl","year":"","journal-title":"Circ. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(03)00101-4","article-title":"Docosahexaenoic acid: membrane properties of a unique fatty acid.","volume":"126","author":"Stillwell","year":"2003","journal-title":"Chem. Phys. Lipids"},{"key":"B63","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0022-2275(20)41904-2","article-title":"Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency.","volume":"32","author":"Stinson","year":"1991","journal-title":"J. Lipid Res."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/srep25509","article-title":"A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.","volume":"6","author":"Sulaiman","year":"2016","journal-title":"Sci. Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1021\/acschembio.7b00854","article-title":"Chemical proteomics reveals soluble epoxide hydrolase as a therapeutic target for ocular neovascularization.","volume":"13","author":"Sulaiman","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2337\/db17-1336","article-title":"Inhibition of soluble epoxide hydrolase 2 ameliorates diabetic keratopathy and impaired wound healing in mouse corneas.","volume":"67","author":"Sun","year":"2018","journal-title":"Diabetes"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.prostaglandins.2014.09.001","article-title":"The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling.","volume":"11","author":"Wagner","year":"2014","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B68","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1535-7163.Mct-16-0818","article-title":"COX-2\/sEH dual inhibitor PTUPB potentiates the antitumor efficacy of cisplatin.","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ijcard.2012.03.167","article-title":"A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARgamma to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.","volume":"167","author":"Xu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"9603","DOI":"10.1073\/pnas.1401191111","article-title":"Cytochrome P450-generated metabolites derived from \u03c9-3 fatty acids attenuate neovascularization.","volume":"111","author":"Yanai","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1073\/pnas.1716016115","article-title":"Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.","volume":"115","author":"Yang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B72","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1124\/jpet.303.2.768","article-title":"Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels.","volume":"303","author":"Ye","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","article-title":"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer.","volume":"53","author":"Zhang","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B75","doi-asserted-by":"publisher","first-page":"H2430","DOI":"10.1152\/ajpheart.2001.280.6.H2430","article-title":"EET homologs potently dilate coronary microvessels and activate BK(Ca) channels.","volume":"280","author":"Zhang","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/shk.0000000000000767","article-title":"Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice.","volume":"47","author":"Zhou","year":"2017","journal-title":"Shock"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T14:14:27Z","timestamp":1662905667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":76,"alternative-id":["10.3389\/fphar.2019.00095"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00095","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"article-number":"95"}}